Boston Scientific posts better-than-expected Q3 earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

Boston Scientific Corp. BSX, -1.90% posted better-than-expected third-quarter earnings early Thursday and raised its full-year guidance. The medical technology company had net income of $505 million, or 34 cents a share, for the quarter, up from $174 million, or 12 cents a share, in the year-earlier period.

Adjusted per-share earnings came to 50 cents, ahead of the 48 cent FactSet consensus. Sales rose to $3.527 billion from $3.170 billion a year ago, also ahead of the $3.477 billion FactSet consensus. The company now expects full-year adjusted EPS of $1.99 to $2.02, while FactSet is expecting $2.00. It expects full-year sales to rise 11%. The stock has gained 8% in the year to date, while the S&P 500 SPX, -1.43% has gained 9%.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 3. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Penske Automotive’s stock slides premarket after profit miss amid ‘challenging’ used car marketCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
출처: MarketWatch - 🏆 3. / 97 더 많은 것을 읽으십시오 »